It was found that the protective effect of Nrf2 against NASH progression was due to its regulation of YAP-mediated NLR family pyrin domain containing 3 (NLRP3) inflammasome activity. Here, YAP1 is linked to metabolic dysfunction-associated steatohepatitis.